Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific manner
Paul J Clark, Alexander J Thompson, David M Vock, Lisa E Kratz, Adviye A Tolun, Andrew J Muir, John G McHutchison, Mani Subramanian, David M Millington, Richard I Kelley, Keyur Patel
Hepatology | WILEY | Published : 2012
Related Projects (1)
Awarded by National Health and Medical Research Council of Australia
Funded by the Duke Clinical Research Institute. Drs. Clark and Thompson received funding from the Duke Clinical Research Institute, the Richard Boebel Family Fund, the National Health and Medical Research Council of Australia (P.J.C.: APP1017139; A.J.T.: APP567057) and the Gastroenterological Society of Australia. Dr. Thompson received funding from the Royal Australian College of Physicians. Dr. Clark received funding from American Association for the Study of Liver Diseases/LIFER Clinical and Translational Research Fellowship in Liver Diseases Award and the National Centre in HIV Epidemiology and Clinical Research (now the Kirby Institute for Infection and Immunity in Society), University of New South Wales, Australia.Potential conflict of interest: Dr. Muir consults for and received grants from Merck, Vertex, Bristol-Myers Squibb, GlaxoSmithKline, and Scynexis. He consults for Achillion and received grants from Gilead, Pfizer, and Abbott.